Near-infrared spectroscopic analysis of blood vessel walls

• US 8,060,187 B2
• Filed: 05/20/2008
• Issued: 11/15/2011
• Est. Priority Date: 08/05/2002
• Status: Expired due to Term

• Current Assignee: Infraredx Incorporated (Nipro Corporation)
• Original Assignee: Infraredx Incorporated (Nipro Corporation)
• Inventors: Tang, Jing, Marshik-Geurts, Barbara J., Zuluaga, Andres
• Primary Examiner(s): Cattungal; Sanjay
• Application Number:
  US12/123,890
• Publication Number:
  US 20080221455A1
• Time in Patent Office: 1,274 Days
• Field of Search: 600473-480, 600/309, 600/310
• US Class Current: 600/473
• CPC Class Codes: A61B 5/0075 by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy A61B5/0071 takes precedence
• CPC Class Codes: A61B 5/0086 using infrared radiation

Abstract

The invention relates to methods and devices for characterizing tissue in vivo, e.g., in walls of blood vessels, to determine whether the tissue is healthy or diseased, and include methods of displaying results with or without thresholds.

Claims

1. An in vivo method for characterizing plaque in a wall of a blood vessel, the method comprising:

through a liquid, illuminating tissue in the wall of the blood vessel with near-infrared radiation within a wavelength range between 1100 nm and 1415 nm;

through a liquid, detecting radiation reflected from the tissue, the radiation consisting of wavelengths between 1100 nm and 1415 nm;

processing the detected radiation to characterize the plaque; and

providing output representative of the plaque characterization.

2. The method of claim 1, wherein said illuminating step is performed using one or more narrow wavelength bands within the wavelength range.

3. The method of claim 2, wherein the one or more narrow wavelength bands each span about 1.0 nm to about 100 nm within the wavelength range.

4. The method of claim 1, wherein said illuminating step is performed using two or more single wavelengths within the wavelength range.

5. The method of claim 1, wherein said illuminating step is performed using at least one single wavelength band at least one single wavelength.

6. The method of claim 1, wherein the wavelength range is 1100 to 1350 nm.

7. The method of claim 1, wherein the wavelength range is 1150 to 1250 nm.

8. The method of claim 1, wherein the wavelength range is 1175 to 1280 nm.

9. The method of claim 1, wherein the wavelength range is 1190 to 1250 nm.

10. The method of claim 1, further comprising:

through a liquid, illuminating the tissue in the blood vessel wall with near-infrared radiation within a second wavelength range of 1600 nm to 1780 nm; and

through a liquid, detecting radiation reflected from the tissue having a second wavelength of from 1600 nm to 1780 nm.

11. The method of claim 10, wherein the second wavelength range is 1650 to 1730 nm.

12. The method of claim 1, further comprising introducing a fiber optic probe into the blood vessel and wherein the illuminating and detecting steps are performed using the probe.

13. The method of claim 1, wherein the liquid includes blood.

14. The method of claim 1, wherein the liquid includes a biocompatible liquid containing at least one of saline, a blood substitute, and an iodine containing liquid.

15. The method of claim 1, wherein said processing step includes characterizing the tissue as healthy or diseased.

16. The method of claim 15, wherein said processing step includes characterizing predominantly lipid tissue as diseased.

17. The method of claim 16, wherein said processing step characterizes predominantly lipid tissue as being vulnerable or potentially vulnerable based on fibrous cap thickness.

18. An apparatus for scanning and characterizing plaque in a wall of a blood vessel in vivo, comprising:

a near-infrared radiation source that generates near-infrared radiation within a wavelength range of 1100 to 1415 nm;

one or more radiation conduits for transmitting radiation from the radiation source, through a fluid, to tissue in the wall of the blood vessel and for receiving, through a fluid, radiation not absorbed by the tissue;

a radiation detector that collects the radiation not absorbed by the tissue across a wavelength range of 1100 to 1415 nm;

a processor that processes the collected radiation to characterize the plaque; and

an output device that indicates the characterization of the plaque.

19. The apparatus of claim 18, wherein the near-infrared radiation source generates a wavelength range of 1150 to 1250 nm.

20. The apparatus of claim 18, wherein the near-infrared radiation source generates a wavelength range of 1100 to 1350 nm.

21. The apparatus of claim 18, wherein the near-infrared radiation source generates two narrow wavelength bands, each spanning 1.0 nm to 30 nm within the wavelength range.

22. The apparatus of claim 18, wherein the near-infrared radiation source generates two or more single wavelengths within the wavelength range.

23. The apparatus of claim 18, further comprising a near-infrared radiation source that generates near-infrared radiation within a second wavelength range of 1600 to 1780 nm.

24. The apparatus of claim 18, wherein the processor characterizes the tissue as healthy or diseased.

25. The apparatus of claim 24, wherein the processor characterizes predominantly lipid tissue as diseased.

26. The apparatus of claim 25, wherein the processor characterizes predominantly lipid tissue as being vulnerable or potentially vulnerable based on fibrous cap thickness.